Targeted radiation zaps prostate cancer in new trial
Disease control
Recruiting now
This study is testing a new radioactive drug called [²¹²Pb]Pb-ADVC001 for men with prostate cancer that has spread. The first part aims to find the safest and most effective dose. The second part will see how well that dose works to control the cancer in different groups of patie…
Phase: PHASE1, PHASE2 • Sponsor: AdvanCell Pty Limited • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC